148
Views
18
CrossRef citations to date
0
Altmetric
Urology

Relation between expression of α1-adrenoceptor mRNAs in bladder mucosa and urodynamic findings in men with lower urinary tract symptoms

, , , , , , & show all
Pages 15-19 | Received 01 Apr 2010, Accepted 02 Aug 2010, Published online: 21 Oct 2010

References

  • Caine M, Pfau A, Perlberg S. The use of alpha adrenergic blockers in benign prostatic obstruction. Br J Urol 1976;48:255–63.
  • Andersson KE. Alpha-adrenoceptors and benign prostatic hyperplasia: basic principles for treatment with alpha-adrenoceptor antagonists. World J Urol 2002;19:390–6.
  • Andersson KE. LUTS treatment: future treatment options. Neurourol Urodyn 2007;26:934–47.
  • Kawabe K, Yoshida M, Homma Y. Silodosin Clinical Study Group. Silodosin, a new α1-adreneroreceptor-selective antagonist for treating benign prostatic hyperplasia: results of a phase III randomized placebo-controlled, double-blind study in Japanese men. BJU Int 2006;98:1019–24.
  • Takahashi S, Tajima A, Matsushima H, Kawamura T, Tominaga T, Kitamura T. Clinical efficacy of an alpha1A/D-adrenoreceptor blocker (naftopidil) on overactive bladder symptoms in patients with benign prostatic hyperplasia. Int J Urol 2006;13:15–20.
  • Das AK, Leggett RE, Whitbeck C, Eagan G, Levin RM. Effect of doxazosin on rat urinary bladder function after partial outlet obstruction. Neurourol Urodyn 2002;21:160–66.
  • Füllhase C, Soler R, Gratzke C, Brodsky M, Christ GJ, Andersson KE Urodynamic evaluation of fesoterodine, doxazosin and their combination in a rat model of partial urethral obstruction. BJU Int 2009 [Epub].
  • Andersson KE. Prostatic and extraprostatic alpha-adrenoceptors – contributions to the lower urinary tract symptoms in benign prostatic hyperplasia. Scand J Urol Nephrol 1996;179:105–11.
  • Andersson KE, Gratzke C. Pharmacology of alpha 1-adrenoceptor antagonists in the lower urinary tract and central nervous system. Nat Clin Pract Urol 2007;4:368–78.
  • Ishihama H, Momota Y, Yanase H, Wang X, de Groat WC, Kawatani M. Activation of α1D adrenergic receptors in the rat urothelium facilitates the micturition reflex. J Urol 2006;175:358–64.
  • Malloy BJ, Price DT, Price RR, Bienstock AM, Dole MK, Funk BL, Alpha1-adrenergic receptor subtypes in human detrusor. J Urol 1998;160:937–43.
  • Hampel C, Dolber PC, Smith MP, Savic SL, Thüroff JW, Thor KB, Modulation of bladder alpha1-adrenergic receptor subtype expression by bladder outlet obstruction. J Urol 2002;167:1513–21.
  • Nomiya M, Yamaguchi O. A quantitative analysis of mRNA expression of alpha 1 and beta-adrenoceptor subtypes and their functional roles in human normal and obstructed bladders. J Urol 2003;170:649–53.
  • Sigala S, Peroni A, Mirabella G, Fornari S, Palazzolo F, Pezzotti G, Alpha1 adrenoceptor subtypes in human urinary bladder: sex and regional comparison. Life Sci 2004;76:417–27.
  • Chen Q, Takahashi S, Zhong S, Hosoda C, Zheng HY, Ogushi T, Function of the lower urinary tract in mice lacking alpha1d-adrenoceptor. J Urol 2005;174:370–4.
  • Bouchelouche K, Andersen L, Alvarez S, Nordling J, Bouchelouche P. Increased contractile response to phenylephrine in detrusor of patients with bladder outlet obstruction: effect of the alpha1A and alpha1D-adrenergic receptor antagonist tamsulosin. J Urol 2005;173:657–61.
  • Chen Z, Ishizuka O, Imamura T, Aizawa N, Igawa Y, Nishizawa O, Role of alpha1-adrenergic receptors in detrusor overactivity induced by cold stress in conscious rats. Neurourol Urodyn 2009;28:251–6.
  • Dmitrieva N, Zhang G, Nagabukuro H. Increased alpha1D adrenergic receptor activity and protein expression in the urinary bladder of aged rats. World J Urol 2008;26:649–55.
  • Barendrecht MM, Frazier EP, Vrydag W, Alewijnse AE, Peters SL, Michel MC. The effect of bladder outlet obstruction on alpha1-and beta-adrenoceptor expression and function. Neurourol Urodyn 2009;28:349–55.
  • Takei R, Ikegaki I, Shibata K, Tsujimoto G, Asano T. Naftopidil, a novel alpha1-adrenoceptor antagonist, displays selective inhibition of canine prostatic pressure and high affinity binding to cloned human alpha1-adrenoceptors. Jpn J Pharmacol 1999;79:447–54.
  • Homma Y, Yoshida M, Seki N, Yokoyama O, Kakizaki H, Gotoh M, Symptom assessment tool for overactive bladder syndrome – Overactive Bladder Symptom Score. Urology 2006;68:318–23.
  • Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, The standardization of terminology in lower urinary tract function: report from the Standardization Sub-committee of the International Continence Society. Neurourol Urodyn 2002;21:167–78.
  • Wyndaele JJ. The normal pattern of perception of bladder filling during cystometry studied in 38 young healthy volunteers. J Urol 1998;160:479–81.
  • Wyndaele JJ, De Wachter S. Cystometrical sensory data from a normal population: comparison of two groups of young healthy volunteers examined with 5 years interval. Eur Urol 2002;42:34–8.
  • Lowe FC. Role of the newer alpha-adrenergic-receptor antagonists in the treatment of benign prostatic hyperplasia-related lower urinary tract symptoms. Clin Ther 2004;26:1701–13.
  • Yanase H, Wang X, Momota Y, Nimura T, Kawatani M. The involvement of urothelial alpha 1A adrenergic receptors in controlling the micturition reflex. Biomed Res 2008;29:239–44.
  • De Wachter S, Van Meel TD, Wyndaele JJ. Can a faked cystometry deceive patients in their perception of filling sensations? A study on the reliability of spontaneously reported cystometric filling sensations in patients with non-neurogenic lower urinary dysfunction. Neurourol Urodyn 2008;27:395–98.
  • Ukimura O, Kanazawa M, Fujihara A, Kamoi K, Okihara K, Miki T. Naftopidil versus tamsulosin hydrochloride for lower urinary tract symptoms associated with benign prostatic hyperplasia with special reference to the storage symptom: a prospective randomized controlled study. Int J Urol 2008;15:1049–54.
  • Ekström B, Andersson KE, Mattiasson A. Urodynamic effects of intravesical instillation of atropine and phentolamine in patients with detrusor hyperactivity. J Urol 1993;149:155–8.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.